Conference Coverage: ASCO 2022 – Focus on Lung Cancer

Expert perspectives and strategic insights on the latest therapeutic developments and translational research in lung cancer treatment.

June 13, 2022
Corey Langer MD Scientific Leader Faculty Chair Aptitude Health

Faculty Chair

Corey J. Langer, MD, FACP

University of Pennsylvania, Philadelphia, PA, USA

FACULTY MEMBERS

TBC

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Immunotherapy in Stage I–III NSCLC
  • Immunotherapy in Stage IV NSCLC
  • EGFR (common mutations): Resectable and Metastatic
  • EGFR (exon 20 and other uncommon mutations)
  • Oncogenic Fusions
  • Oncogenic Mutations
  • Other Targets in NSCLC/SCLC

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.